Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solesence (SLSN) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Solesence (SLSN) over the last 16 years, with Q3 2025 value amounting to $4.8 million.

  • Solesence's Accounts Payables fell 2645.53% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 2645.53%. This contributed to the annual value of $9.1 million for FY2024, which is 4525.56% up from last year.
  • According to the latest figures from Q3 2025, Solesence's Accounts Payables is $4.8 million, which was down 2645.53% from $6.9 million recorded in Q2 2025.
  • Solesence's 5-year Accounts Payables high stood at $9.2 million for Q1 2025, and its period low was $2.4 million during Q3 2021.
  • For the 5-year period, Solesence's Accounts Payables averaged around $5.5 million, with its median value being $5.6 million (2024).
  • As far as peak fluctuations go, Solesence's Accounts Payables skyrocketed by 12151.07% in 2022, and later plummeted by 2645.53% in 2025.
  • Quarter analysis of 5 years shows Solesence's Accounts Payables stood at $3.6 million in 2021, then surged by 78.44% to $6.4 million in 2022, then decreased by 1.62% to $6.3 million in 2023, then soared by 45.26% to $9.1 million in 2024, then tumbled by 46.93% to $4.8 million in 2025.
  • Its Accounts Payables stands at $4.8 million for Q3 2025, versus $6.9 million for Q2 2025 and $9.2 million for Q1 2025.